Cargando…
The AGREE Enterprise: a decade of advancing clinical practice guidelines
BACKGROUND: The original AGREE (A ppraisal of G uidelines for RE search and E valuation) Instrument was published in 2003, and its revision, the AGREE II, in 2009. Together, they filled an important gap in the guideline and quality of care fields. Ten years later, the AGREE Enterprise reflects on a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148001/ https://www.ncbi.nlm.nih.gov/pubmed/25123781 http://dx.doi.org/10.1186/s13012-014-0103-2 |
_version_ | 1782332545742929920 |
---|---|
author | Makarski, Julie Brouwers, Melissa C |
author_facet | Makarski, Julie Brouwers, Melissa C |
author_sort | Makarski, Julie |
collection | PubMed |
description | BACKGROUND: The original AGREE (A ppraisal of G uidelines for RE search and E valuation) Instrument was published in 2003, and its revision, the AGREE II, in 2009. Together, they filled an important gap in the guideline and quality of care fields. Ten years later, the AGREE Enterprise reflects on a trajectory of projects and international collaboration that have contributed to advancing the science and quality of practice guidelines and the uptake of AGREE/AGREE II. FINDINGS: The AGREE Enterprise has undertaken activities to improve the tool and to develop resources to support its use. Since 2003, the uptake and adoption of AGREE by the international community has been swift and broad. A total of 33 language translations of the original AGREE Instrument and the current AGREE II are available and were initiated by the international community. A recent scan of the published literature identified over 600 articles that referenced the AGREE tools. The AGREE tools have been widely received and applied, with several organizations having incorporated the AGREE as part of their formal practice guideline programs. Since its redevelopment in 2010, the AGREE Enterprise website (www.agreetrust.org) continues to experience steady increases in visitors per month and currently has over 10,000 registered users. CONCLUSIONS: The AGREE Enterprise has contributed to the advancements of guidelines through research activities and international participation by scientific and user communities. As we enter a new decade, we look forward to ongoing collaborations and contributing to further advancements to improve quality of care and health care systems. |
format | Online Article Text |
id | pubmed-4148001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41480012014-08-29 The AGREE Enterprise: a decade of advancing clinical practice guidelines Makarski, Julie Brouwers, Melissa C Implement Sci Short Report BACKGROUND: The original AGREE (A ppraisal of G uidelines for RE search and E valuation) Instrument was published in 2003, and its revision, the AGREE II, in 2009. Together, they filled an important gap in the guideline and quality of care fields. Ten years later, the AGREE Enterprise reflects on a trajectory of projects and international collaboration that have contributed to advancing the science and quality of practice guidelines and the uptake of AGREE/AGREE II. FINDINGS: The AGREE Enterprise has undertaken activities to improve the tool and to develop resources to support its use. Since 2003, the uptake and adoption of AGREE by the international community has been swift and broad. A total of 33 language translations of the original AGREE Instrument and the current AGREE II are available and were initiated by the international community. A recent scan of the published literature identified over 600 articles that referenced the AGREE tools. The AGREE tools have been widely received and applied, with several organizations having incorporated the AGREE as part of their formal practice guideline programs. Since its redevelopment in 2010, the AGREE Enterprise website (www.agreetrust.org) continues to experience steady increases in visitors per month and currently has over 10,000 registered users. CONCLUSIONS: The AGREE Enterprise has contributed to the advancements of guidelines through research activities and international participation by scientific and user communities. As we enter a new decade, we look forward to ongoing collaborations and contributing to further advancements to improve quality of care and health care systems. BioMed Central 2014-08-15 /pmc/articles/PMC4148001/ /pubmed/25123781 http://dx.doi.org/10.1186/s13012-014-0103-2 Text en © Makarski and Brouwers; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Makarski, Julie Brouwers, Melissa C The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title | The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title_full | The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title_fullStr | The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title_full_unstemmed | The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title_short | The AGREE Enterprise: a decade of advancing clinical practice guidelines |
title_sort | agree enterprise: a decade of advancing clinical practice guidelines |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148001/ https://www.ncbi.nlm.nih.gov/pubmed/25123781 http://dx.doi.org/10.1186/s13012-014-0103-2 |
work_keys_str_mv | AT makarskijulie theagreeenterpriseadecadeofadvancingclinicalpracticeguidelines AT brouwersmelissac theagreeenterpriseadecadeofadvancingclinicalpracticeguidelines AT makarskijulie agreeenterpriseadecadeofadvancingclinicalpracticeguidelines AT brouwersmelissac agreeenterpriseadecadeofadvancingclinicalpracticeguidelines |